Novartis buys 12.8 pct stake in BioLineRX in co-development deal
December 16, 2014 at 07:19 AM EST
JERUSALEM, Dec 16 (Reuters) - Swiss drugmaker Novartis AG bought a 12.8 percent stake in Israeli biopharmaceutical company BioLineRX Ltd as part of a multi-year collaboration deal, BioLineRX said on Tuesday.
